Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Eledon Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
We are focused, we are agile, we are driven, we do not cut corners, and we are guided by data and science. We are using this approach to develop and commercialize next generation anti-CD40 Ligand (CD40L) antibodies for patients in need of a potentially life-saving treatment. With AT-1501 as the cornerstone of our pipeline, Eledon is poised to leverage our expertise in both anti-CD40 Ligand biology and drug development to advan...
We are focused, we are agile, we are driven, we do not cut corners, and we are guided by data and science. We are using this approach to develop and commercialize next generation anti-CD40 Ligand (CD40L) antibodies for patients in need of a potentially life-saving treatment. With AT-1501 as the cornerstone of our pipeline, Eledon is poised to leverage our expertise in both anti-CD40 Ligand biology and drug development to advance therapies seeking to help patients undergoing organ or cellular transplantation, as well as those living with autoimmune or neurodegenerative diseases, all of whom face limited options.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Eledon Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
19900 MacArthur Blvd., Suite 550 Irvine, California 92612
Telephone
Telephone
+1 949-238-8090

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY